US Patent Issued to Seoul National University R&DB Foundation, Sungkwang Medical Foundation on May 12 for "Nanovesicles from adult stem cells and its use for targeted therapy" (South Korean Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,928, issued on May 12, was assigned to Seoul National University R&DB Foundation (Seoul, South Korea) and Sungkwang Medical Foundation (Seoul, South Korea).

"Nanovesicles from adult stem cells and its use for targeted therapy" was invented by Byung-Soo Kim (Seoul, South Korea), Han Young Kim (Seoul, South Korea), In Bo Han (Seoul, South Korea) and Hemant Kumar (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a nanovesicles from adult stem cells containing iron nanoparticles and its use. The nanovesicle according to the present disclosure provides effects of maximizing the efficacy of treating mesenchymal stem cel...